Library

Protocol

Testagen (20mg Vial)

Complete dosage protocol and reconstitution guide for Testagen (20mg Vial).

Updated November 27, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismTestagen is a synthetic tetrapeptide with the sequence Lys‑Glu‑Asp‑Gly (KEDG), an anterior pituitary‑derived bioregulator studied for its role in modulating endocrine function, particularly the pituitary–gonadal axis [1] [2] . Preclinical research indicates effects on thyroid hormone normalization and male reproductive hormone modulation [3] [4] .
Dosing100–300 mcg once daily (gradual titration).
ReconstitutionAdd 3.0 mL diluent to a 20 mg vial.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.

Calculator preset

Run the vial math before tracking.

At ~6.67 mg/mL, 1 unit ~ 66.7 mcg ; 100 mcg ~ 1.5 units and 200 mcg ~ 3 units . Doses are small - a 30/50-unit syringe reads best.

Calculate this vial

01 · At a glance

Quickstart Highlights

Testagen is a synthetic tetrapeptide with the sequence Lys‑Glu‑Asp‑Gly (KEDG), an anterior pituitary‑derived bioregulator studied for its role in modulating endocrine function, particularly the pituitary–gonadal axis [1] [2] . Preclinical research indicates effects on thyroid hormone normalization and male reproductive hormone modulation [3] [4] . This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

ReconstituteAdd 3.0 mL bacteriostatic water → ~ 6.67 mg/mL concentration.
Reference dose100–300 mcg once daily (gradual titration).
Easy measuringAt ~6.67 mg/mL, 1 unit ~ 66.7 mcg ; 100 mcg ~ 1.5 units and 200 mcg ~ 3 units . Doses are small - a 30/50-unit syringe reads best.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~6.67 mg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–2100 mcg (0.1 mg)1.5 units (0.015 mL)
Weeks 3–4150 mcg (0.15 mg)2.25 units (0.0225 mL)
Weeks 5–8200 mcg (0.2 mg)3 units (0.03 mL)
Weeks 9–12(optional) 250–300 mcg (0.25–0.3 mg) 3.75–4.5 units (0.0375–0.045 mL)

100–300 mcg once daily (gradual titration).

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake) [5] .
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide Vials 8 weeks (~14 mg used) ≈ 1 vial
  • 12 weeks (~25 mg used) ≈ 2 vials
  • 16 weeks (~36 mg used) ≈ 2 vials
Insulin Syringes Per week: 7 syringes (1/day)
  • 8 weeks: 56 syringes
  • 12 weeks: 84 syringes
  • 16 weeks: 112 syringes
Bacteriostatic Water Use ~3.0 mL per vial for reconstitution.
  • 8 weeks (1 vial): 3 mL → 1 × 10 mL bottle
  • 12 weeks (2 vials): 6 mL → 1 × 10 mL bottle
  • 16 weeks (2 vials): 6 mL → 1 × 10 mL bottle
Alcohol Swabs One for the vial stopper + one for the injection site each day.
  • Per week: 14 swabs (2/day)
  • 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
  • 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
  • 16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Protocol Overview

  • Goal: Support endocrine function research, particularly pituitary–gonadal axis modulation [1] [2] .
  • Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
  • Dose Range: 100–300 mcg daily with gradual titration.
  • Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

  • Suggested daily titration approach.
  • Start: 100 mcg daily; increase by ~50 mcg every 2 weeks as tolerated.
  • Target: 200–300 mcg daily by Weeks 5–12.
  • Frequency: Once per day (subcutaneous).
  • Cycle Length: 8–12 weeks; optional extension to 16 weeks.
  • Timing: Any consistent time; rotate injection sites.

Storage Instructions

  • Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
  • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

  • Practical considerations for consistency and safety.
  • Use new sterile insulin syringes; dispose in a sharps container [7] .
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation [8] .
  • Inject slowly; wait a few seconds before withdrawing the needle.
  • Document daily dose and site rotation to maintain consistency.
  • Due to very low injection volumes (≤5 units), a 30‑ or 50‑unit syringe is recommended for precision.

05 · How it works

How This Works

Testagen is a synthetic tetrapeptide with the sequence Lys‑Glu‑Asp‑Gly (KEDG), an anterior pituitary‑derived bioregulator studied for its role in modulating endocrine function, particularly the pituitary–gonadal axis [1] [2] .

Preclinical research indicates effects on thyroid hormone normalization and male reproductive hormone modulation [3] [4] .

This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • Testagen observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.